With food allergies on the rise, biotech Aimmune is focusing on raising patients' tolerance
June 28, 2018 at 14:30 PM EDT
Jim Cramer sits down with Stephen Dilly, the founding executive chairman and former CEO of Aimmune Therapeutics, to discuss the latest in food allergy treatment.
